CpG blocks suppression by MDSC Zoglmeier et al. Page 1 of 24 CpG blocks immune suppression by myeloid-derived suppressor cells in tumor- bearing mice

نویسندگان

  • Christine Zoglmeier
  • Helen Bauer
  • Daniel Nörenberg
  • Georg Wedekind
  • Philipp Bittner
  • Nadja Sandholzer
  • Moritz Rapp
  • David Anz
  • Stefan Endres
  • Carole Bourquin
چکیده

Authors Affiliations: Division of Clinical Pharmacology and Center of Integrated Protein Science Munich, Munich, Germany Financial support: This work was supported by grants from the LMUexcellent research professorship (to S.E.), the German Research Foundation: DFG En 169/7-2 and Graduiertenkolleg 1202 (to C.B. and S.E.), the excellence cluster Center for Integrated Protein Science Munich 114 (to S.E.), BayImmuNet (to C.B. and S.E.) and the Friedrich-Baur Foundation and Weigand-Gravenhorst Foundation (to C.Z). This work is part of the doctoral theses of H.B., D.N., G.W. and P.B. at the Ludwig-Maximilian University of Munich.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

Purpose: The Toll-like receptor (TLR) 9 ligand CpG has been used successfully for the immunotherapy of cancer. Chronic CpG application in tumor-free hosts leads, however, to the expansion of myeloidderived suppressor cells (MDSC), which can cause T-cell suppression and may thus hamper the development of an effective immune response. Here, we investigated the effect of TLR9 activation on the fun...

متن کامل

Correction: CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice.

PURPOSE The Toll-like receptor (TLR) 9 ligand CpG has been used successfully for the immunotherapy of cancer. Chronic CpG application in tumor-free hosts leads, however, to the expansion of myeloid-derived suppressor cells (MDSC), which can cause T-cell suppression and may thus hamper the development of an effective immune response. Here, we investigated the effect of TLR9 activation on the fun...

متن کامل

A new mechanism for blocking myeloid-derived suppressor cells by CpG.

In this issue of Clinical Cancer Research, Zoglmeier and colleagues show that CpG, via the induction of IFN-α, matures myeloid-derived suppressor cells to abrogate immune suppression in 2 murine solid tumor models.

متن کامل

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5- fluorouracil chemotherapy in the B16 melanoma model

Our previous studies demonstrated that anti-CD40 mAb (anti-CD40) can synergize with CpG oligodeoxynucleotides (CpG) to mediate antitumor effects by activating myeloid cells, such as macrophages in tumor-bearing mice. Separate teams have shown that chemotherapy with gemcitabine (GEM) or 5-fluorouracil (5-FU) can reduce tumor-induced myeloid-derived suppressor cells (MDSC) in mice. In this study ...

متن کامل

Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.

Suppression of tumor-specific T cell sensitization is a predominant mechanism of tumor escape. To identify tumor-induced suppressor cells, we transferred spleen cells from mice bearing progressive MCA205 sarcoma into sublethally irradiated mice. These mice were then inoculated subdermally with tumor cells to stimulate T cell response in the tumor-draining lymph-node (TDLN). Tumor progression in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011